Biotech · Private company
NFlection Therapeutics, Inc.
Track this companyFree. Adds NFlection Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- NFX-179 gelPhase 2 · Cutaneous NeurofibromaClinicalTrials.gov · fetched Nov 12, 2026
- NFX-179 GelPhase 2 · Neurofibromatosis 1ClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle gelPhase 2 · Cutaneous NeurofibromaClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle GelPhase 2 · Neurofibromatosis 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- 12-week Study of NFX-179 Gel in Subjects With Epidermal NeviPHASE2 · WITHDRAWN · started Jun 1, 2023ClinicalTrials.gov NCT05195762 · fetched Nov 12, 2026
- NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)PHASE2 · COMPLETED · started Sep 29, 2021ClinicalTrials.gov NCT05005845 · fetched Nov 12, 2026
- NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)PHASE2 · COMPLETED · started Aug 21, 2020ClinicalTrials.gov NCT04435665 · fetched Nov 12, 2026